CARGO Therapeutics to Participate in Upcoming Investor Conferences

SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will be participating in the following investor conferences. TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA Gina Chapman, President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat on Tuesda ...